The data clearly shows ivermectin led to 70% fewer deaths, 60% less mechanical ventilation, and 25% fewer ICU admissions. But none of those amounts are reported as statistically significant...<p>"3 (1.2%) vs 10 (4%) 28-day in-hospital deaths...Mechanical ventilation occurred in 4 (1.7%) vs 10 (4.0%)...intensive care unit admission in 6 (2.4%) vs 8 (3.2%)" (ivermectin vs. non-ivermectin)<p>These authors made a huge mistake. They didn't check the odds of all these secondary differences being slanted towards ivermectin at once. A series of low-but-above-.05 P values in the same direction show correlation even more strongly than a single near-.05 P value does.<p>Also, the principal result is more narrowly-scoped than reported. Though within its scope, the study's accurate: When high-risk patients wait 4-7+ days since first COVID symptoms to decide to visit a clinic and for a PCR test to come back positive, ivermectin doesn't reduce "progression to severe COVID". But ivermectin nevertheless prevents many cases of secondary COVID effects in high-risk patients, like death and need for ventilator.